UNIT 6: CENTRAL NEUROTRANSMITTERS (PART 2) Flashcards
T/F
Neurotransmitter must be present in higher concentratiuon in the synaptic area than in other areas
True
T/F
Neurotransmitters are released by electrical or chemical stimulation via calcium-dependent mechanism
True
T/F
Synaptic Mimicry is the production of same postsynaptic response and is seen with physiologic activation of the synapse
True
Which Neurotransmitter is being described:
G protein-coupled muscarininc M1 Receptors?
a. Acetylcholine
b. Dopamine
c. Norepinephrine
d. serotonin
a. Acetylcholine
Which Neurotransmitter is being described:
* Slows excitation
* Decreeases permeanility to potassium
a. Acetylcholine
b. Dopamine
c. Norepinephrine
d. serotonin
a. Acetylcholine
Which Neurotransmitter is being described:
* Increases cAMP
a. Acetylcholine
b. Dopamine
c. Norepinephrine
d. serotonin
b. Dopamine
Which Neurotransmitter is being described
* G protein-coupled activation of K+ channels
a. Acetylcholine
b. Dopamine
c. Norepinephrine
d. serotonin
b. Dopamine
Which Neurotransmitter is being described
* has both excitatory and inhibitory response
a. Acetylcholine
b. Dopamine
c. Norepinephrine
d. serotonin
c. Norepinephrine
Which Neurotransmitter is being described
* Excitatory: decreases K+ conductance
a. Acetylcholine
b. Dopamine
c. Norepinephrine
d. serotonin
c. Norepinephrine
Which Neurotransmitter is being described
* Inhibitory: increases K+ conductance
a. Acetylcholine
b. Dopamine
c. Norepinephrine
d. serotonin
c. Norepinephrine
Which Neurotransmitter is being described
* Multip;e 5 hydroxytrptamine
* Excitatoru depending on the receptor subtype activated
a. Acetylcholine
b. Dopamine
c. Norepinephrine
d. Serotonin
d. Serotonin
Which Neurotransmitter is being described
* Excitatory for most neurons
* NMDA receptor
* Inhibition of adenyl cyclase
a. Glutamic Acid
b. GABA
c. Glycine
d. Opioid Peptides
Glutamic Acid
Which Neurotransmitter is being described
* Primary NTA mediating IPSPs
a. Glutamic Acid
b. GABA
c. Glycine
d. Opioid Peptides
GABA
Which Neurotransmitter is being described
* Numerous in the cord
* Inhibitory
* Increase CL conductance
a. Glutamic Acid
b. GABA
c. Glycine
d. Opioid Peptides
Glycine
Which Neurotransmitter is being described
* Beta-endorphins, dynorphins
a. Glutamic Acid
b. GABA
c. Glycine
d. Opioid Peptides
Opiod Peptides
List Amino Acid Neurotransmitters
- Glutamate
- GABA
- Glycine
Amino Acid NTA that mediates excitatory synaptic transmission
a. Glutamate
b. GABA & Glycine
Glutamate
T/F
Glutamate interact with AMPA and NMDA (ionotropic receptor) on presynaptic and MGLUR (metabotropic) on posysynaptic
True
Aminoacid NTA that is inhibitory neurotransmitter
a. Glutamate
b. Gaba
c. Glycine
d. Both b and c
d. Both b and c
Inhibitory NTA present throughtout the CNS including the spinal cord
a. GABA
b. Glycine
c. Both a & b
GABA
Inhibitory NTA present in Spinal Cord and Brain Stem
a. GABA
b. Glycine
c. Both a & b
b. Glycine
Its receptors are pentameric sturctures and are selectively permeable to CL-
a. GABA
b. Glycine
c. Both a & b
b. Glycine
A potent spinal cord convulsant that selectively blocks glycine receptors
Strychnine
Ionotropic Receptor ** which Pentameric structures that are selectively permeable to Cl-**
a. GABAa
b. GABAb
a. GABAa
NTA that Causes slow inhibition of the neuron by activating the M2 subtype of receptor, which opens potassium channels.
a. Acetylcholine
b. Dopamine
c. Norepinephrine
d. Histamine
a. Acetylcholine
Metabotropic receptor that isSelectively activated by the antispastic drug baclofen.
a. GABAa
b. GABAb
b. GABAb
NTA that mediates large family of G protein-coupled muscarining receptors
a. Acetylcholine
b. Dopamine
c. Norepinephrine
d. Histamine
a. Acetylcholine
List down the Monoamine Neurotransmitters
a. Dopamine
b. Norepinephrine
c. 5-hydroxytryptamine
d. Histamine
Which Monoamine NTA is described
* all are metabotropic
* Exerts slow inhibitory actions
a. Dopamine
b. Norepinephrine
c. 5-hydroxytryptamine
d. Histamine
a. Dopamine
Which Monoamine transmitter is described
* located in the locus coeruleus or lateral tegmental area of the reticular formation
a. Dopamine
b. Norepinephrine
c. 5-hydroxytryptamine
d. Histamine
b. Norepinephrine
Which Monoamine transmitter is described
* Hyperpolarizes neurons by increasing potassium conductance
a. Dopamine
b. Norepinephrine
c. 5-hydroxytryptamine
d. Histamine
b. Norepinephrine
Which Monoamine transmitter is described
* Enhances excitatory by both direct and indirect mechanism
a. Dopamine
b. Norepinephrine
c. 5-hydroxytryptamine
d. Histamine
b. Norepinephrine
Which Monoamine transmitter is described
* Contained in unmyelinated fibers that diffusely innervate most regions of the CNS
a. Dopamine
b. Norepinephrine
c. 5-hydroxytryptamine
d. Histamine
c. 5-hydroxytryptamine
Which Monoamine transmitter is described
* Both excitatory and inhibitory actions can occur on the same neuron
* Regulates brain functions
a. Dopamine
b. Norepinephrine
c. 5-hydroxytryptamine
d. Histamine
c. 5-hydroxytryptamine
Which Monoamine transmitter is described
* Originated from neurons in the midline raphe nuclei of the pons and upper brain stem
a. Dopamine
b. Norepinephrine
c. 5-hydroxytryptamine
d. Histamine
c. 5-hydroxytryptamine
Which Monoamine transmitter is described
* Made in the tuberomammillary nucleus
* all are matobotropic
* for sedative properties
a. Dopamine
b. Norepinephrine
c. 5-hydroxytryptamine
d. Histamine
d. Histamine
Neuropeptide produced in the lateral and posterior hypothalamus
Orexin
Neuropeptide that releases glutamate
Orexin
Neuropeptide that Exhibit firing patterns associated with wakefulness and project to and activate monoamine and acetylcholine neurons involved in sleep-wake cycles.
Orexin
List the other signaling substances
- Endocanbinoids
- Nitric Oxide
- Purines
Which other signaling substance is described?
* Activated by calcium-calmodulin
* Activation of NMDA receptors
a. Endocannibinoids
b. Nitric Oxide
c. Purines
d. Nitric Oxide
Which other signaling substance is described?
* Can function as retrograde synaptic messengers
a. Endocannibinoids
b. Nitric Oxide
c. Purines
a. Endocannibinoids